维普中文期刊产品整合服务
38篇 您的检索式:作者名="WIENEN W"
    题名 作者 年代 出处 被引量
1Pharmacological characterization of the novel nonpeptide angiotension Ⅱ receptor antagonist,BIBR 277显示文摘Wienen W Hauel N Van Meel J C A 1993Br J Pharmacol1993,110,1:1
2In-vitro profile and ex-vivo antico- agulant activity of the direct thromhin inhibitor dabigatran and its orally ac- tive prodrug,dabigatranetexilate显示文摘Wienen W Stassen JM Priepke H 2007Thromb Haemost2007,98,:1
3Pharmacological characterization of the novel nonpeptide angiotensin Ⅱ receptor antagonist,BIBR 277显示文摘WIENEN W HAUEL N VAN MEEL JC 1993Br J Pharmacol1993,110,1:1
4Pharmacological characterization of the novel nonpeptide angiotensinⅡ receptor antagonist, BIBR 277显示文摘Wienen W Hauel N Van Meel JC Narr B Ries U Entzeroth M 1993Br J Pharmacol1993,110,1:1
5Review on telmisartan: a novel long-acting angiotensinⅡ receptor antagonist显示文摘Wienen W Entzeroth M van Meel JCA Stangier J Busch U Ebner T 2000Cardiovasc Drug Rev2000,18,:1
6Effects of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate,on thrombus formation and bleeding time in rats显示文摘WIENEN W STASSEN JM PRIEPKE H 2007Thromb Haemost2007,98,2:1
7Comparative antih- ypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats 显示文摘Wienen W Richard S Champeroux P 2001J Renin Angiotensin Aldosterone Syst2001,2,1:1
8AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin Ⅱ in conscious rats显示文摘Gohlke P Weiss S Jansen A Wienen W 2001J Pharmacol Exp Ther2001,298,1:1
9Reduction of cardiac hypertrophy in TGR (mREN2) 27 by angiotensin Ⅱ receptor blockade显示文摘Bohm M Lippoldt A Wienen W 1996Mol Cell Biochem1996,163,164:1
10In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran andits orally active prodrug,dabigatran etexilate显示文摘Wienen W Stassen JM Priepke H 2007Thromb Haemost2007,98,1:1
11Pharmacological characterization of the novel nonpeptide angiotensin Ⅱ receptor antagonist,BIBR 277显示文摘Wienen W Hauel N Van MJCA 1993Br J Pharmacol1993,110,9:1
12Pharmacological characterization of the novel no peptide angiotension Ⅱ receptor antagonist,BIBR-277显示文摘Wienen W Hauel N Van meel JCA 1993Br J Pharmacol1993,110,:1
13Pharmacological characterization of the novel nonpeptide angiotensin Ⅱ receptor antagonist,BIBR 277显示文摘WIENEN W HAUEL N VAN MEEL JC 1993Br J Pharmacol1993,110,1:1
14Pharmacological characterization of the novel nonpeptide angitension Ⅱ receptor antagonist,BIBR 277显示文摘Wienen W Hauel N Van Meel JCA 1993Br J Pharmacol1993,110,1:1
15Antithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran,and its oral prodrug,dabigatran etexilate,in a rabbit model of venous thrombosis显示文摘 STASSEN JM PRIEPKE H 2007J Thromb Haemost2007,5,6:1
16Pharmacologicalcharacterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277显示文摘Wienen W Hauel N Van Meel JC Narr B Ries U Entzeroth M 1993Br J Pharmacol1993,110,:1
17Pharmacological characterization of the novel nonpeptide angiotension Ⅱ receptor antagonist,BIBR 277显示文摘WIENEN W HAUEL N VAN MEEL J C A 1993Br J Pharmacol1993,110,:1
18In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active pro- drug dabigatran etexilate 显示文摘Wienen W Stassen JM Priepke H 2007Thromb Haemost2007,98,2:1
19In-vitro profile and ex-vi- vo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate显示文摘Wienen W Stassen JM Priepke H 2007Thromb Hae- most2007,98,1:1
20Pharmacological characterization of the novel nonpeptide angiotension Ⅱ receptor antagonist,BIBR-277显示文摘Wienen W Hauel N Van meel JCA 1993Br J Pharmacol1993,110,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费